Serious & occasionally fatal hypersensitivity (anaphylactoid) reactions in patients receiving penicillin or cephalosporin therapy; previous hypersensitivity reactions to penicillins, cephalosporins or other allergens. Discontinue treatment & administer antihistamines, pressor amines, corticosteroids if allergic or anaphylactic reactions, redness, irritation, or swelling occur; if results of identification & susceptibility testing indicate infection is due to organism other than penicillinase producing Staph susceptible to cloxacillin Na. Not effective against methicillin-resistant strains of Staph. CNS adverse effects including myoclonia, convulsive seizures & depressed consciousness. Candidiasis & other superinfections especially in debilitated & malnourished patients, or those w/ low resistance to infection due to corticosteroids, immunosuppressors or irradiation. Development of drug resistant bacteria. Consider culture & susceptibility information in selecting or modifying antibacterial therapy. Periodically check renal, hepatic & hematopoietic functions during long-term therapy. Pregnancy. Premature & newborn infants (frequent evaluation of organ system function).